Talphera
Company Details
Status: Public
Employees: 101-250
Location:
California, United States of America
Type:
sample
Technology:
sample
sample
About: Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera’s lead product candidate, Niyad is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation Status from the FDA. Talphera is also developing two pre-filled syringes in-licensed from its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.
To learn more about the development status of these product candidates, please visit our website at www.talphera.com.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!

Talphera | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.